Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Step Therapy Legislation in the States: Navigating a Varied & Complex System

Joseph Cantrell, JD  |  July 17, 2019

Lagging again are Iowa and Minnesota, with a five-day requirement, while Ohio has a 10-day requirement that will go into effect on Jan. 1, 2020. While these response times are far from desirable, they still provide some timeline, even though they will still result in delays in care for patients.

Override for Previously Failed Steps
One of the most important provisions of any step therapy bill is the inclusion of an automatic exception for a patient who has previously failed a step. This protects patients from having to repeat medications that have already proven to be ineffective for them. Twenty-one states currently have this exception in their state laws, with Georgia, Ohio and Wisconsin’s protections becoming effective on Jan. 1, 2020. Washington state’s will again go into effect in January 2021.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Override for Contraindication
Of all the override exceptions, this may seem like the most obvious: A patient should not take a drug that would likely cause them harm. While this may seem like a common-sense exception, its inclusion in step therapy laws is far from universal. Twenty states currently have an exception for contraindications. Georgia, Ohio, Oklahoma and Wisconsin’s provisions will go into effect in January 2020, while Washington’s will go into effect in January 2021.

Override for Stable Patients
Again, this may seem like a common-sense override exception, but only 15 states currently have overrides for stable patients. This is a particularly important exception for patients who are stable on a biologic. As you likely know, many patients who are stable on a biologic may not respond the same if they are switched to a different drug and then try to switch back to the original biologic. Although we cannot fully explain this phenomenon, we do know how to prevent it: Do not require stable patients to switch medications.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Your Role in Changing the Conversation
As a physician, you are not only a trusted resource for your patients, you are also capable of being a trusted resource for your local legislator. State legislators often depend on local experts from their districts for advice on complex issues like health policy. It is important for you to get to know your local legislative delegation where they live and work.

District meetings are one of the best places to establish meaningful and impactful relationships with legislators. You may often find yourself meeting them at a local coffee shop or restaurant instead of in an office. This kind of personal meeting has proven time and time again to be more effective than capitol office meetings. The legislator may be more relaxed and receptive, and may have more time than during a typical office meeting.

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:overridestep therapy state legislation

Related Articles

    State Step Therapy Laws: Not All Are Created Equal

    April 8, 2019

    Step therapy reform has been a hot topic and major focus of the ACR’s advocacy activity in states this legislative session. Washington, Oregon, Wisconsin and Florida are all considering step therapy bills that stand good chance of passing this legislative year. Virginia and Georgia have already passed step therapy laws. When these two new laws…

    The 21st Century Cures Act Information-Blocking Rule

    April 17, 2021

    The 21st Century Cures Act (Cures Act) became law on Dec. 13, 2016, and emphasized interoperability in the exchange of healthcare information between healthcare providers, health information entities and patients. The Cures Act underscored unimpeded access to patient electronic health information (EHI) upon request, in a manner that is secure and updated automatically, and prohibits…

    The ACR and Partners Help Get Legislation Passed in New York to Limit Step Therapy

    August 4, 2016

    In June, state lawmakers in New York passed legislation on step therapy designed to help ensure patient access to the best and most appropriate care. Step therapy mandates that a patient with a specific condition receive prescribed drugs approved for that condition in the order that an insurance company determines it will cover as the…

    Drug UPDATES

    March 18, 2011

    Information on New Approvals and Medication Safety

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences